General Information on CeNeS Acquisition
In 2008 PAION acquired the company CeNeS Pharmaceuticals plc based in Cambridge, Great Britain. The drugs Remimazolam, M6G und Solulin derive from this transaction.
News:
Ad hoc release: PAION AG completes acquisition of CeNeS
23 June 2008
press release: PAION AG completes acquisition of CeNeS
23 June 2008
Press release: Court sanctions Scheme of Arrangement for acquisition of CeNeS
20 June 2008
Regulatory release: AIM Prospective Admission
11 June 2008
Press release: Shareholders of CeNeS vote for acquisition by PAION
28 May 2008
Press release: PAION Annual General Meeting and CeNeS Acquisition Update
6 May 2008
Ad-hoc PAION AG intends to acquire CeNeS Pharmaceuticals plc
10 April 2008
press PAION AG intends to acquire CeNeS Pharmaceuticals plc
10 April 2008
Documents:
Scheme Document
7. Mai 2008
2.5 Announcement
10. April 2008
Prospectus:
PAION Prospectus for the Public Offer and Admission to Trading of up to 7,850,000 ordinary no-par value bearer shares
16.05.2008